Lupin Pharmaceuticals is voluntarily recalling the blood pressure medication Quinapril Tablets because an impurity was detected in recent testing, the Food and Drug Administration said this week.
The potential presence of a nitrosamine impurity has prompted Lupin Pharmaceuticals to issue a recall of some blood pressure medication, per an announcement.
Quinapril is prescribed to around a million Americans each year to treat hypertension and heart failure. However, testing at various sites found excessive amounts of nitrosamine in the pills.
The US FDA has issued a recall of the blood pressure medication Quinapril, made by Lupin Pharmaceuticals, was voluntarily recalled on Wednesday due to concerns over the medication increasing cancer risk.